CSF biomarkers in idiopathic normal pressure hydrocephalus- Diagnostics and pathophysiology by Jeppsson, Anna
Göteborg, 2019 
SAHLGRENSKA AKADEMIN 
CSF biomarkers in idiopathic normal pressure hydrocephalus 
Diagnostics and pathophysiology 
Akademisk avhandling 
Som för avläggande av medicine doktorsexamen vid Sahlgrenska akademin, Göteborgs 
universitet kommer att offentligen försvaras i hörsal Arvid Carlsson, Medicinaregatan 3, 
den 14 juni 2019, klockan 13.00 
Av Anna Jeppsson 
Fakultetsopponent: 
Professor Neill R. Graff-Radford 
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA 
Avhandlingen baseras på följande delarbeten 
I.  Jeppsson, A, Zetterberg, H, Blennow, K, Wikkelsø, C.  
Idiopathic normal-pressure hydrocephalus- Pathophysiology and diagnosis by 
CSF biomarkers. Neurology 2013;80:1385-1392. 
II. Jeppsson A, Holtta M, Zetterberg H, Blennow K, Wikkelsø C, Tullberg M. 
Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus. Fluids 
Barriers CNS 2016;13:13. 
III. Jeppsson, A, Wikkelsø, C,  Blennow, K,  Zetterberg, H,  Constantinescu, R, 
Remes A M, Herukka, S-K, Rauramaa, T Nägga, K, Leinonen, V, Tullberg, 
M. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus 
from its mimics. Accepted for publication in Journal of Neurology, Neurosurgery & 
Psychiatry 
IV. Jeppsson, A, Bjerke, M, Hellström, P, Blennow, K, Zetterberg, H, Kettunen, 
P, Wikkelsø, C, Wallin, A, Tullberg, M.  
CSF biomarkers highlight pathophysiological similarities and differences in 
idiopathic normal pressure hydrocephalus and subcortical small vessel 
disease. Manuscript 
 
INSTITUTIONEN FÖR NEUROVETENSKAP OCH 
FYSIOLOGI 
Göteborg, 2019 
ISBN 978-91-7833-426-1 (PRINT)  
ISBN 978-91-7833-427-8 (PDF) 
http://hdl.handle.net/2077/59547 
 
CSF biomarkers in idiopathic normal pressure hydrocephalus 
Diagnostics and pathophysiology 
Anna Jeppsson 
Sektionen för klinisk neurovetenskap, Institutionen för neurovetenskap och fysiologi, Sahlgrenska 
akademin, Göteborgs universitet, Sverige. 
Abstract 
Idiopathic normal pressure hydrocephalus (iNPH) is a disease of the elderly with enlarged 
ventricles despite a normal CSF pressure. Clinically, iNPH presents with gait- and balance 
disturbances, cognitive decline and incontinence. As the symptoms are reversed by shunt 
surgery, precise diagnostics is of essence. As of today, the etiology of the disease is largely 
unknown and specific diagnostic and prognostic tests are lacking.  
The overall aim of this thesis project was to explore the diagnostic and prognostic potential 
of CSF biomarkers in iNPH. By measuring markers reflecting different pathophysiological 
aspects, we also wanted to elucidate underlying pathophysiologic mechanisms of iNPH.  
In paper I, we showed that NFL was elevated and amyloid precursor protein (APP)–derived 
proteins and tau proteins were lower in patients with iNPH than in healthy individuals (HI). 
Post-surgery, there was an increase of NFL, APP-derived proteins, p-tau, and albumin in 
ventricular CSF, whereas levels of MBP and T-tau decreased. In paper II the concentrations 
of all soluble forms of APP, all Aβ isoforms and APL1β28 were lower, whilst APL1β25 and 
APL1β27 were higher in CSF of iNPH patients compared to HI. No difference could be 
seen in biomarker concentrations between patients who improved after surgery and those 
who did not. In paper III, iNPH patients had lower concentrations of tau and APP-derived 
proteins in combination with elevated MCP-1 compared to HI and the most important dif-
ferential diagnostic disorders. A prediction algorithm consisting of T-tau, Aβ40 and MCP-1 
was designed as a diagnostic tool showing high discriminating ability. In paper IV all soluble 
forms of APP and all Aβ isoforms were lower in both subcortical small vessel disease (SSVD) 
and iNPH in comparison to HI, albeit with a more pronounced reduction in iNPH. INPH 
and SSVD had elevated concentrations of NFL, MBP and GFAP compared to HI. 
Our findings indicate that patients with iNPH have a CSF biomarker profile that distin-
guishes them from HI of the same age as well as from their mimics.  The profile is charac-
terized by a downregulation of APP-proteins, CSF biomarkers reflecting destruction to the 
white matter and astrocyte activation but no substantial cortical damage. Analysis of CSF 
biomarkers may provide an important tool for diagnosing patients with iNPH.  
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